FDA Oncologic Drugs Advisory Committee
The FDA's Oncologic Drugs Advisory Committee will discuss new drug applications for NDA 022-042, EVISTA (raloxifene hydrochloride) Tablets, Eli Lilly…
Network with fellow health care journalists and gain valuable insights you can use every day.
Everyone should have access to quality health care information so they can make informed decisions. Join AHCJ today for exclusive access to training and education to inform your community.